Anixa Biosciences Inc (ANIX)

$2.76 +0.03 (1.10%)
Market Cap 92.08M
Revenue (ttm) 0.00
Net Income (ttm) -12.55M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 41,500
Avg Vol 96,732
Day's Range N/A - N/A
Shares Out 32.20M
Stochastic %K 14%
Beta 0.86
Analysts Strong Sell
Price Target $9.00

Latest News on ANIX

Anixa Biosciences to Present at the Jones Las Vegas Healthcare and Technology Innovation Conference on April 9th

Apr 1, 2025, 8:00 AM EDT - 1 day ago

Anixa Biosciences to Present at the Jones Las Vegas Healthcare and Technology Innovation Conference on April 9th

Anixa Biosciences Enters Letter of Intent with VERDI Solutions to Develop Artificial Intelligence-Guided Personalized and Off-the-Shelf Cancer Vaccines

Mar 25, 2025, 8:00 AM EDT - 8 days ago

Anixa Biosciences Enters Letter of Intent with VERDI Solutions to Develop Artificial Intelligence-Guided Personalized and Off-the-Shelf Cancer Vaccines

Anixa Biosciences Receives Notice of Allowance from USPTO for Ovarian Cancer Vaccine

Mar 24, 2025, 8:00 AM EDT - 9 days ago

Anixa Biosciences Receives Notice of Allowance from USPTO for Ovarian Cancer Vaccine

Anixa Biosciences CEO to Present at the 2025 CAGLA NeauxCancer Conference on March 28th

Mar 17, 2025, 8:00 AM EDT - 16 days ago

Anixa Biosciences CEO to Present at the 2025 CAGLA NeauxCancer Conference on March 28th

Anixa Biosciences 2025 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties

Mar 10, 2025, 8:30 AM EDT - 23 days ago

Anixa Biosciences 2025 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties

Anixa Biosciences Announces Chief Development Officer Dr. Pam Garzone to Speak at the Alliance for Cancer Gene Therapy Summit 2025 on March 19th

Mar 3, 2025, 8:00 AM EST - 4 weeks ago

Anixa Biosciences Announces Chief Development Officer Dr. Pam Garzone to Speak at the Alliance for Cancer Gene Therapy Summit 2025 on March 19th

Anixa Biosciences and Moffitt Cancer Center Complete Dosing in Third Cohort in Ovarian Cancer CAR-T Clinical Trial

Feb 26, 2025, 8:00 AM EST - 5 weeks ago

Anixa Biosciences and Moffitt Cancer Center Complete Dosing in Third Cohort in Ovarian Cancer CAR-T Clinical Trial

Anixa Biosciences' Breast Cancer Vaccine was Featured on Fox News' "America Reports"

Feb 25, 2025, 7:30 AM EST - 5 weeks ago

Anixa Biosciences' Breast Cancer Vaccine was Featured on Fox News' "America Reports"

Anixa Biosciences Featured in Breaking Cancer News Article on Novel CAR-T Therapy for Ovarian Cancer

Feb 24, 2025, 8:00 AM EST - 5 weeks ago

Anixa Biosciences Featured in Breaking Cancer News Article on Novel CAR-T Therapy for Ovarian Cancer

Anixa Biosciences Announces Approval of Protocol Amendment for Ovarian Cancer CAR-T Clinical Trial

Feb 18, 2025, 8:00 AM EST - 6 weeks ago

Anixa Biosciences Announces Approval of Protocol Amendment for Ovarian Cancer CAR-T Clinical Trial

Anixa Biosciences Chairman and CEO Discusses Pioneering CAR-T Cell Therapy and Breast Cancer Vaccine in Alpha Wolf Trading Interview

Feb 14, 2025, 7:00 AM EST - 6 weeks ago

Anixa Biosciences Chairman and CEO Discusses Pioneering CAR-T Cell Therapy and Breast Cancer Vaccine in Alpha Wolf Trading Interview

Anixa Biosciences to Present at the 18th Annual European Life Sciences CEO Forum

Feb 11, 2025, 8:30 AM EST - 7 weeks ago

Anixa Biosciences to Present at the 18th Annual European Life Sciences CEO Forum

Anixa Biosciences' Chairman & CEO Dr. Amit Kumar Featured on CW39's H-Town Live to Discuss the Future of Breast Cancer Prevention

Feb 4, 2025, 8:30 AM EST - 2 months ago

Anixa Biosciences' Chairman & CEO Dr. Amit Kumar Featured on CW39's H-Town Live to Discuss the Future of Breast Cancer Prevention

Anixa Biosciences CEO Provides Letter to Shareholders

Jan 21, 2025, 8:30 AM EST - 2 months ago

Anixa Biosciences CEO Provides Letter to Shareholders

Anixa Biosciences to Present at the iAccess Alpha Virtual Best Ideas Winter Conference 2024 on December 10

Dec 4, 2024, 8:30 AM EST - 4 months ago

Anixa Biosciences to Present at the iAccess Alpha Virtual Best Ideas Winter Conference 2024 on December 10

Anixa Biosciences Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset

Nov 22, 2024, 8:15 AM EST - 4 months ago

Anixa Biosciences Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset

Anixa Biosciences Initiates Dosing in Third Cohort in its Ovarian Cancer CAR-T Clinical Trial

Nov 18, 2024, 8:20 AM EST - 4 months ago

Anixa Biosciences Initiates Dosing in Third Cohort in its Ovarian Cancer CAR-T Clinical Trial

Anixa Biosciences and Cleveland Clinic Present New Updated Positive Data from Phase 1 Study of Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting

Nov 8, 2024, 1:17 PM EST - 5 months ago

Anixa Biosciences and Cleveland Clinic Present New Updated Positive Data from Phase 1 Study of Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting

Anixa Biosciences Announces Timing of Public Release of Data from the Phase 1 Study of its Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting

Nov 6, 2024, 8:30 AM EST - 5 months ago

Anixa Biosciences Announces Timing of Public Release of Data from the Phase 1 Study of its Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting

Anixa Biosciences to Present at the Sidoti Micro-Cap Virtual Conference on November 13 & 14, 2024

Oct 31, 2024, 8:15 AM EDT - 5 months ago

Anixa Biosciences to Present at the Sidoti Micro-Cap Virtual Conference on November 13 & 14, 2024

Anixa Biosciences and Cleveland Clinic to Present Additional Data from Phase 1 Study of Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting

Oct 28, 2024, 8:30 AM EDT - 5 months ago

Anixa Biosciences and Cleveland Clinic to Present Additional Data from Phase 1 Study of Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting

Anixa Biosciences Announces Second Dose Administered to Patient in Ovarian Cancer CAR-T Clinical Trial

Oct 15, 2024, 9:00 AM EDT - 6 months ago

Anixa Biosciences Announces Second Dose Administered to Patient in Ovarian Cancer CAR-T Clinical Trial

Anixa Biosciences Appoints Suyasha Gupta as Senior Director of Clinical Development

Oct 7, 2024, 8:30 AM EDT - 6 months ago

Anixa Biosciences Appoints Suyasha Gupta as Senior Director of Clinical Development

Anixa Biosciences Announces Submission of Protocol Amendment for CAR-T Trial

Sep 30, 2024, 8:30 AM EDT - 6 months ago

Anixa Biosciences Announces Submission of Protocol Amendment for CAR-T Trial

Anixa Biosciences Unveils Phase 2 Study Plan for Breast Cancer Vaccine

Sep 24, 2024, 8:30 AM EDT - 6 months ago

Anixa Biosciences Unveils Phase 2 Study Plan for Breast Cancer Vaccine

Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Therapy at the Ovarian Cancer Research Alliance's International Gynecologic Cancer Conference

Sep 18, 2024, 8:30 AM EDT - 7 months ago

Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Therapy at the Ovarian Cancer Research Alliance's International Gynecologic Cancer Conference

Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Therapy at the Rivkin Center-AACR 15th Biennial Ovarian Cancer Research Symposium

Sep 3, 2024, 8:30 AM EDT - 7 months ago

Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Therapy at the Rivkin Center-AACR 15th Biennial Ovarian Cancer Research Symposium

Anixa Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Aug 26, 2024, 8:30 AM EDT - 7 months ago

Anixa Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Clinical Trial at the International Gynecologic Cancer Society 2024 Annual Meeting

Jul 29, 2024, 8:45 AM EDT - 8 months ago

Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Clinical Trial at the International Gynecologic Cancer Society 2024 Annual Meeting

Anixa Biosciences Announces FDA Approval of Individual Patient IND for its Ovarian Cancer CAR-T Therapy

Jul 23, 2024, 8:15 AM EDT - 9 months ago

Anixa Biosciences Announces FDA Approval of Individual Patient IND for its Ovarian Cancer CAR-T Therapy

Anixa Biosciences Announces Japanese Patent on Breast Cancer Vaccine Technology

Jul 17, 2024, 8:00 AM EDT - 9 months ago

Anixa Biosciences Announces Japanese Patent on Breast Cancer Vaccine Technology

Anixa Biosciences Announces $5 Million Share Repurchase Program

Jul 15, 2024, 8:30 AM EDT - 9 months ago

Anixa Biosciences Announces $5 Million Share Repurchase Program

Anixa Biosciences Treats Sixth Patient in its Ovarian Cancer CAR-T Clinical Trial

Jun 24, 2024, 8:45 AM EDT - 10 months ago

Anixa Biosciences Treats Sixth Patient in its Ovarian Cancer CAR-T Clinical Trial

Anixa Biosciences Commences Treatment of Fifth Patient in Ovarian Cancer CAR-T Clinical Trial

May 21, 2024, 7:30 AM EDT - 11 months ago

Anixa Biosciences Commences Treatment of Fifth Patient in Ovarian Cancer CAR-T Clinical Trial

Anixa Biosciences Expands Partnership with Cleveland Clinic to Develop Additional Cancer Vaccines

May 8, 2024, 8:25 AM EDT - 11 months ago

Anixa Biosciences Expands Partnership with Cleveland Clinic to Develop Additional Cancer Vaccines

Anixa Biosciences CEO Featured on "Target: Cancer Podcast" by Oncologist Dr. Sanjay Juneja

May 6, 2024, 8:05 AM EDT - 11 months ago

Anixa Biosciences CEO Featured on "Target: Cancer Podcast" by Oncologist Dr. Sanjay Juneja

Anixa Biosciences to Participate in the Sidoti Micro-Cap Virtual Conference on May 8 & 9, 2024

Apr 30, 2024, 7:45 AM EDT - 1 year ago

Anixa Biosciences to Participate in the Sidoti Micro-Cap Virtual Conference on May 8 & 9, 2024

Anixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business Advisory Board

Apr 18, 2024, 8:20 AM EDT - 1 year ago

Anixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business Advisory Board

Anixa Biosciences 2024 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties

Mar 14, 2024, 8:45 AM EDT - 1 year ago

Anixa Biosciences 2024 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties

Anixa Biosciences Announces Presentation at 24th Annual World Vaccine Congress

Mar 11, 2024, 8:00 AM EDT - 1 year ago

Anixa Biosciences Announces Presentation at 24th Annual World Vaccine Congress

Anixa Biosciences Initiates Dosing in Second Cohort of Ovarian Cancer CAR-T Clinical Trial

Feb 12, 2024, 7:30 AM EST - 1 year ago

Anixa Biosciences Initiates Dosing in Second Cohort of Ovarian Cancer CAR-T Clinical Trial

Anixa Biosciences Announces Participation in 2024 NeauxCancer Oncology Conference

Jan 29, 2024, 8:50 AM EST - 1 year ago

Anixa Biosciences Announces Participation in 2024 NeauxCancer Oncology Conference

Anixa Biosciences Announces Japanese Patent on Ovarian Cancer Vaccine Technology

Jan 23, 2024, 7:55 AM EST - 1 year ago

Anixa Biosciences Announces Japanese Patent on Ovarian Cancer Vaccine Technology

Anixa Biosciences to Present at Sidoti Micro-Cap Virtual Conference on January 17, 2024

Jan 10, 2024, 9:00 AM EST - 1 year ago

Anixa Biosciences to Present at Sidoti Micro-Cap Virtual Conference on January 17, 2024

Anixa Biosciences to Present at Biotech Showcase 2024

Dec 14, 2023, 7:15 AM EST - 1 year ago

Anixa Biosciences to Present at Biotech Showcase 2024

Anixa Biosciences and Cleveland Clinic Present Positive New Data from Phase 1 Study of Breast Cancer Vaccine

Dec 6, 2023, 6:00 PM EST - 1 year ago

Anixa Biosciences and Cleveland Clinic Present Positive New Data from Phase 1 Study of Breast Cancer Vaccine

Anixa Biosciences to Host Conference Call This Evening to Discuss Positive New Data from Ongoing Phase 1 Study of Breast Cancer Vaccine

Dec 6, 2023, 4:05 PM EST - 1 year ago

Anixa Biosciences to Host Conference Call This Evening to Discuss Positive New Data from Ongoing Phase 1 Study of Breast Cancer Vaccine

Anixa Biosciences Announces European Patent on Ovarian Cancer Vaccine Technology

Nov 27, 2023, 8:30 AM EST - 1 year ago

Anixa Biosciences Announces European Patent on Ovarian Cancer Vaccine Technology

Anixa Biosciences to Present at the Ovarian Cancer Research Alliance (OCRA) Ovarian Cancer National Conference

Oct 31, 2023, 8:30 AM EDT - 1 year ago

Anixa Biosciences to Present at the Ovarian Cancer Research Alliance (OCRA) Ovarian Cancer National Conference

Anixa Biosciences Appoints Accomplished Medical Oncologist and Biotechnology Executive, Dr. Mark A. Goldberg, to Cancer Business Advisory Board

Oct 23, 2023, 8:30 AM EDT - 1 year ago

Anixa Biosciences Appoints Accomplished Medical Oncologist and Biotechnology Executive, Dr. Mark A. Goldberg, to Cancer Business Advisory Board